Structure and function of the dopamine transporter

European Journal of Pharmacology

Volumn 405, Issue 1-3, 2000, Pages 329-339

  Chen, Nianhang ^a,b   Reith, Maarten E A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chimera; Cocaine; Cocaine analog; Dopamine transporter; Phosphorylation; Site directed mutagenesis

Indexed keywords

AMINO ACID; COCAINE; COCAINE DERIVATIVE; CYSTEINE; DOPAMINE; DOPAMINE TRANSPORTER; ENVIRONMENTAL CHEMICAL; THIOL REAGENT; TOXIN;

AMINO ACID SEQUENCE; BINDING SITE; CHIMERA; CONFERENCE PAPER; DOPAMINE UPTAKE; HUMAN; MOLECULAR CLONING; NERVE CELL; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS;

ANIMAL; CARRIER PROTEINS; COCAINE; DOPAMINE UPTAKE INHIBITORS; HUMAN; KINETICS; RECEPTORS, DOPAMINE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034730676     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00563-X     Document Type: Conference Paper

References (94)

1. Neurotransmitter transporters as molecular targets for addictive drugs
2. Transmembrane domain 1 contributes to the permeation pathway for serotonin and ions in the serotonin transporter
3. Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species?
4. Transport and drug binding kinetics in membrane vesicle preparation
5. Role of protein kinase C and second messengers in regulation of the norepinephrine transporter
6. Molecular cloning and functional expression of the mouse dopamine transporter
7. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium
8. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants
9. Aromatic-aromatic interactions in proteins
10. External cysteines in the serotonin transporter
11. The third transmembrane domain of the serotonin trasnporter contains residues associated with substrate and cocaine binding
12. Determination of External loop topology in the serotonin transporter by site-directed chemical labeling
13. Permeation and gating residues in serotonin transporter
14. Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transporter
15. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake
16. Transport-dependent accessibility of a cytoplasmic loop cystine in the human dopamine transporter
17. Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine
18. Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport
19. Cation-pi interactions in chemistry and biology: a new view of benzene, phe, Tyr, and Trp
20. A multisubstrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine
21. A putative model of the dopamine transporter
22. Release of dopamine via the human transporter
23. Characterization of a recombinant human dopamine transporter in multiple cell lines
24. Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter
25. Cloning and functional characterization of a cocaine-sensitive dopamine transporter
26. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter
27. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters
28. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
29. The reactivity of the γ-aminobutyric acid transporter GAT-1 toward sulfhydryl reagents is conformationally sensitive
30. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra
31. Phorbol esters increase dopamine transporter phosphorylation and decrease transport V(max)
32. Transmembrane proline resides and dopamine transport function
33. Dopamine transporter transmembrane polar mutants: evidence for interactions important for transporter functions
34. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter
35. 3H]Substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux
36. Profound neuronal plasticity in response to inactivation of the dopamine transporter
37. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter
38. Cloning and expression of a cocaine-sensitive rate dopamine transporter
39. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding
40. + transport
41. Phorbol esters alter functions of the expressed dopamine transporter
42. + toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters
43. The dopamine transporter carboxyl-terminal tail
44. + uptake and cocaine binding in bovine dopamine transporter
45. Protein kinase C-mediated regulation of dopamine transporter is not achieved by direct phosphorylation on the transporter
46. 3H]WIN 35,428 to the human dopamine transporter
47. - with the binding of amphetamine, octopamine, and tyramine to the human dopamine transporter
48. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition
49. Selective influences on dopamine uptake and cocaine analog binding by alanine substitutions for dopamine transporter transmembrane domain residues
50. Defining proximity relationship in the tertiary structure of the dopamine transporter
51. Striatal Transporter for dopamine: Catechol structure-activity studies and susceptibility to chemical modification
52. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition
53. Membrane trafficking regulates the activity of the human dopamine transporter
54. Structure activity relationships of inhibition of the dopamine transporter by 3-arylbicyclo[3,2,1]octanes
55. Point mutations of the human dopamine transporter (hDAT) reveal differential binding of an amine and a non-amine ligand
56. Dopamine trasnporters and neuronal injury
57. Molecular mapping of the sites on rat dopamine transporter for specific recognition of 1-methyl-4-phenylpyridium
58. Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine
59. N-Linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition
60. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons
61. Delineation of an endogenous zinc-binding site in the human dopamine transporter
62. Neurotransmitter transporter protines
63. Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cell transfected with the cloned human catecholamine transporters
64. Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion
65. The structure and function of norepinephrine, dopamine, and serotonin transporters
66. 3H]GBR 12, 935 binding
67. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter
68. Protein kinase C activation regulates human serotonin transporter in HEK-293 cells via altered cell surface expression
69. Ca2+-dependent phosphorylation of dopamine transporter upregulates its transporter activity
70. Phosphorylation and sequestration of serotonin transporter differentially modulated by psychostimulants
71. Cocaine and other inhibitors of dopamine uptake promote different conformational changes in the dopamine transporter
72. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA
73. Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter
74. The role of external loop regions in serotonin transport
75. Multiple ionic conductances of human dopamine transporter: the actions of dopamine and psychostimulants
76. Structure and function of G protein-coupled receptors
77. A cognate dopamine transporter-like activity endogenously expressed in a COS-7 kidney-derived cell line
78. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
79. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development
80. Cloning of the cocaine-sensitive bovine dopamine transporter
81. A human dopamine transporter cDNA predicts reduced glycosylation, display a novel repetitive element and provides racially-dimorphic Taq I RFLPs
82. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping
83. Dopamine transporter ligand binding domains
84. Species- and brain region-specific dopamine transporters: immunological and glycosylation characteristics
85. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes
86. Differential binding of tropane-based photoaffinity ligands on the dopamine transporter
87. The effect of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter
88. Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression
89. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux
90. Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue
91. Translocation of dopamine and binding of 2β-cabomethoxy-β-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers
92. Regulation of the functional activity of the human dopamine transporter by protein kinase C
93. Activation of protein kinase C inhibits uuptake, currents and binding associated with the human dopamine transporter expressed in Xenopus Oocytes